drugset / Trial / NCT00168064

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

NCT00168064

Phase 2 Completed 260 enrolled Yaupon Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy, tolerability and safety of the topical application of mechlorethamine (MCH) formulations in patients with stage I or IIA mycosis fungoides (MF).

Timeline

Start
2006-05
Primary completion
2010-08
Completion
2011-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator mechlorethamine Small molecule 0.02 % Topical

Indications